| Bioactivity | Succinyl-Coenzyme A (Succinyl-CoA) is an intermediate of the citric acid cycle. Succinyl-Coenzyme A can be converted to succinic acid and can also combines with glycine to form δ-amino levulinic acid (ALA) to synthesize porphyrins (heme). Succinyl-Coenzyme A can be used in the study of metabolic, neurological and haematological abnormalities (such as porphyrias) caused by nutritional vitamin B12 deficiency (resulting in a deficiency in Succinyl-Coenzyme A synthesis)[1][2]. |
| CAS | 604-98-8 |
| Formula | C25H40N7O19P3S |
| Molar Mass | 867.61 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Bicakci Z. Growth retardation, general hypotonia, and loss of acquired neuromotor skills in the infants of mothers with cobalamin deficiency and the possible role of succinyl-CoA and glycine in the pathogenesis. Medicine (Baltimore). 2015 Mar;94(9):e584. [2]. Bonkovsky HL, et al. Porphyrin and heme metabolism and the porphyrias. Compr Physiol. 2013 Jan;3(1):365-401. |
Succinyl CoA
CAS: 604-98-8 F: C25H40N7O19P3S W: 867.61
Succinyl-Coenzyme A (Succinyl-CoA) is an intermediate of the citric acid cycle. Succinyl-Coenzyme A can be converted to
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.